After oral administration of live oral vaccines COLINFANT and MUTAFLOR
prepared from non-enteropathogenic E.coli strains, both strains colon
ized effectively the intestine in full-term and preterm infants and re
mained for many weeks showing, that they were capable to establish the
mself as a resident strain in the infant's gut, The presence of E,coli
stimulated significantly antibody production in gut, saliva and serum
of colonized infants. An early induction of secretory IgA production
is important particularly in formula-fed infants, where it partly repl
aces the lacking immunoglobulin supplied with mother milk. In full-ter
m and premature infants the early presence of non-pathogenic E.coli st
rains in the intestine decreased significantly the presence of pathoge
nic bacterial strains in the intestine but also other mucosal surfaces
of the body. The COLINFANT strain decreased the number of nosocomial
infections, mortality rate in connection with infection, and the need
for antibiotics. Both strains replaced successfully pathogenic strains
in carriers after treatment with antibiotics.